Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest Update

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 2,200 shares, a growth of 46.7% from the March 31st total of 1,500 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 23,800 shares, the short-interest ratio is presently 0.1 days.

Institutional Investors Weigh In On Bellevue Life Sciences Acquisition

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Condor Capital Management purchased a new stake in shares of Bellevue Life Sciences Acquisition during the 4th quarter worth about $121,000. Cowen AND Company LLC acquired a new position in Bellevue Life Sciences Acquisition during the 4th quarter worth approximately $165,000. Wealthspring Capital LLC acquired a new stake in Bellevue Life Sciences Acquisition in the third quarter valued at approximately $209,000. Robinson Capital Management LLC purchased a new stake in Bellevue Life Sciences Acquisition during the 3rd quarter worth $438,000. Finally, Deltec Asset Management LLC purchased a new position in Bellevue Life Sciences Acquisition in the 3rd quarter valued at about $1,105,000. 55.30% of the stock is currently owned by institutional investors and hedge funds.

Bellevue Life Sciences Acquisition Trading Up 0.2 %

Shares of BLAC traded up $0.03 during trading hours on Friday, hitting $10.71. The stock had a trading volume of 374,100 shares, compared to its average volume of 27,023. Bellevue Life Sciences Acquisition has a 12-month low of $10.11 and a 12-month high of $11.16. The company’s fifty day simple moving average is $10.66 and its 200 day simple moving average is $10.55.

Bellevue Life Sciences Acquisition Company Profile

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.